Guy Wendy
SEC insider (Form 3/4/5 filer). CIK 0001799360. Chief Administrative Officer at Processa Pharmaceuticals, Inc. (PCSA). 13 reported Form 4/5 transactions since Sep 2024; latest on Jul 26, 2026. Located in VERO BEACH, FL.
Companies Guy Wendy has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Officer, Chief Administrative Officer
Guy Wendy
CIK: 0001799360
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
9.5K shares- - Jun 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.4K shares at avg. $1.93$5K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $2.22$5K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.57$5K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.6K shares at avg. $2.97$5K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.7K shares at avg. $2.69$5K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.6K shares at avg. $2.97$5K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.9K shares at avg. $2.54$5K - Jan 1, 2026PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect193 shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 9,450 | - | - | Direct |
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,436 | $1.93 | $4,701 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,118 | $2.22 | $4,702 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,829 | $2.57 | $4,701 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,583 | $2.97 | $4,702 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,748 | $2.69 | $4,702 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,583 | $2.97 | $4,702 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,854 | $2.54 | $4,700 | Direct |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Exercise | 193 | - | $0 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 50,000 | - | - | Direct |
1-10 of 13 transactions